4//SEC Filing
Golembiewski Michael Joseph 4
Accession 0001136261-22-000041
CIK 0001017491other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 4:27 PM ET
Size
5.6 KB
Accession
0001136261-22-000041
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-10+500,000→ 500,000 totalExercise: $1.46Exp: 2032-01-10→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on January 10, 2023, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.
Documents
Issuer
SEELOS THERAPEUTICS, INC.
CIK 0001017491
Entity typeother
Related Parties
1- filerCIK 0001639479
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 4:27 PM ET
- Size
- 5.6 KB